{"id":"W2111615347","doi":"10.1136/gutjnl-2011-301769","title":"A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis","year":2012,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Dr. Falk Pharma; Genentech; Amgen","keywords":"Medicine; Ulcerative colitis; Adverse effect; Pharmacokinetics; Placebo; Gastroenterology; Internal medicine; Pharmacodynamics; Cohort; Surgery; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002165192,0.0001401756,0.0001983874,0.00006049515,0.00003888977,0.00001042873,0.0001165015,0.00007078931,0.00005473586],"category_scores_gemma":[0.00009690241,0.0001392356,0.00005756094,0.00006970275,0.00002318653,0.000007163681,0.00007607933,0.0000587677,0.00002288002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002955579,"about_ca_system_score_gemma":0.00007711826,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000321168,"about_ca_topic_score_gemma":0.000242923,"domain_scores_codex":[0.9989271,0.0001965355,0.0002576647,0.0002108012,0.0001236737,0.0002842099],"domain_scores_gemma":[0.9993957,0.00001047227,0.00006541044,0.0002975316,0.00007754412,0.0001533704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5220069,0.01864904,0.06837328,0.0002922351,0.001148653,0.0006239975,0.03758752,0.00524457,0.3270786,0.0008028668,0.008545487,0.009646857],"study_design_scores_gemma":[0.3973205,0.004253137,0.5138777,0.00008145656,0.0002048715,0.00003960927,0.006380782,0.0008744946,0.07179249,0.0001423289,0.003510419,0.001522199],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969768,0.00004785082,0.0001121268,0.00001461011,0.00007676953,0.0009982887,0.00004850154,0.000007209732,0.001717828],"genre_scores_gemma":[0.9991189,0.000003370904,0.00007017727,0.000137983,0.0001131104,0.0001931556,0.00003160941,0.00001836223,0.0003132984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4455045,"threshold_uncertainty_score":0.5677865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01257131216444834,"score_gpt":0.2859849772664441,"score_spread":0.2734136651019957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}